The shares are marginally negative as compared to the S&P 500 for the past week with a loss of 1.17 percent, and the company has underperformed the index by 2.51 percent in the last month.
Stryker stock has a 52-week high price of $98.24 and a 52-week low price of $75.78.
More articles on devices:
Smith & Nephew, Misonix, Precision Spine & more — 22 key notes
Smith & Nephew insider sells 11k+ shares
Wright Medical Group’s “neutral” rating reaffirmed by Zacks
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
